Philippa Marrack

National Jewish Health — United States

Immunology and Microbiology · Life Sciences

132h-index61.6kcitations519works12.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

T-cell and B-cell Immunology(332), Immune Cell Function and Interaction(304), Immunotherapy and Immune Responses(160), Monoclonal and Polyclonal Antibodies Research(110), CAR-T cell therapy research(51)

Publications519 total

MHC heterozygosity limits T cell receptor variability in CD4 T cells
Science Immunology·2024· 12 cited
Vaccine-elicited B- and T-cell immunity to SARS-CoV-2 is impaired in chronic lung disease patients
ERJ Open Research·2023· 6 citedOpen Access
Vaccine-elicited B and T cell immunity to SARS-CoV-2 is impaired in chronic lung disease patients
2023· 1 citedOpen Access
MHC Heterozygosity Reduces the T Cell Receptor Repertoire
SSRN Electronic Journal·2023· 1 citedOpen Access
The broad spectrum of pathogenic autoreactivity
Nature reviews. Immunology·2022· 11 citedOpen Access
The Receptor Binding Domain of SARS-CoV-2 Lambda Variant Has a Better Chance Than the Delta Variant in Evading BNT162b2 COVID-19 mRNA Vaccine-Induced Humoral Immunity
International Journal of Molecular Sciences·2022· 6 citedOpen Access
SARS-CoV-2 Variants of Concern and Variants of Interest Receptor Binding Domain Mutations and Virus Infectivity
Frontiers in Immunology·2022· 83 citedOpen Access
The Lambda variant of SARS-CoV-2 has a better chance than the Delta variant to escape vaccines
2021· 37 citedOpen Access
Structures suggest an approach for converting weak self-peptide tumor antigens into superagonists for CD8 T cells in cancer
Proceedings of the National Academy of Sciences·2021· 26 citedOpen Access
The basis of a more contagious 501Y.V1 variant of SARS-CoV-2
Cell Research·2021· 165 citedOpen Access
Rational discovery of a cancer neoepitope harboring the KRAS G12D driver mutation
Science China Life Sciences·2021· 10 cited
501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to Bamlanivimab <i>in vitro</i>
2021· 33 citedOpen Access
The basis of a more contagious 501Y.V1 variant of SARS-COV-2
2021· 36 citedOpen Access
501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab <i>in vitro</i>
mAbs·2021· 78 citedOpen Access
Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy
OncoImmunology·2021· 23 citedOpen Access
Lysosomal cathepsin creates chimeric epitopes for diabetogenic CD4 T cells via transpeptidation
The Journal of Experimental Medicine·2020· 56 citedOpen Access
Tolerance induction in memory CD4 T cells is partial and reversible
Immunology·2020· 8 citedOpen Access
JMJD5 couples with CDK9 to release the paused RNA polymerase II
Proceedings of the National Academy of Sciences·2020· 14 citedOpen Access
Age-associated B Cells Appear in Patients with Granulomatous Lung Diseases
American Journal of Respiratory and Critical Care Medicine·2020· 32 citedOpen Access
Tolerance induction in memory CD4 T cells is partial and reversible
2020Open Access
page 1 of 26Next →

Frequent Co-authors

John W. Kappler(39), J W Kappler(6), Brian L. Kotzin(6), David A. Hildeman(5), Ralph T. Kubo(4), Janice White(4), Yongwon Choi(4), Kathryn Haskins(4), Neal W. Roehm(3), Ann M. Pullen(3), Deno P. Dialynas(3), Frank W. Fitch(3), Tom Mitchell(3), Richard Shimonkevitz(3), Marcia A. Blackman(3), Andrew Herman(2), D B Wilde(2), Amy S. McKee(2), Michael W. Munks(2), Michele Pigeon(2)